Your last comment is more the probem peace. We basically have...

Your last comment is more the probem peace. We basically have enough money IF they did get a tax refund of approx 2 mil to last until christmas. It now all hinges on getting this license from Janssen. Even then what kind of payment could we expect there. Another 5 million is required to stay in business for the next calendar year. Maybe turning a negative into a positive why would Janssen sign a license deal for millions of dollars with a company that it appears is only worth sub 10 million currently. I would think a buy out is more likeky if they achieve the targets to trivger a license. It appears they are still wirking with pfizer ans with that new collaboration recently therr could be some bidders if an auction started? Realistically if there are any major descoveries in the near future surely a buy out is most ikely. The only question is what would they pay. Probabky all relative to what a license would cost to maintain instead.